Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study

Summary

To determine if a strategy of early discharge using a novel subcutaneous delivery system for parenteral furosemide can improve clinical outcomes within 30 days of randomization (days alive and outside the hospital) compared to usual care.

Timeline

Start

2018-04-27

Primary completion

2018-09-20

Completion

2018-09-20

Drugs

Indications